Clearday, Inc. (CLRD)
USD 0.07
(0.0%)
USD 0.07
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2022 | 5 Million USD | -19.96% |
| 2021 | 30.41 Million USD | 17.15% |
| 2020 | 25.95 Million USD | 313.95% |
| 2019 | 6.27 Million USD | -99.92% |
| 2018 | 7.53 Billion USD | 7.06% |
| 2017 | 7.03 Billion USD | 88638.97% |
| 2016 | 7.93 Million USD | -20.41% |
| 2015 | 9.96 Million USD | -99.91% |
| 2014 | 11.38 Billion USD | 2.15% |
| 2013 | 11.14 Billion USD | 4.76% |
| 2012 | 10.63 Billion USD | 90595.89% |
| 2011 | 11.72 Million USD | -23.53% |
| 2010 | 15.33 Million USD | -56.34% |
| 2009 | 35.12 Million USD | -99.77% |
| 2008 | 15.33 Billion USD | 7.99% |
| 2007 | 14.2 Billion USD | -59.57% |
| 2006 | 35.12 Billion USD | 78.68% |
| 2005 | 19.65 Billion USD | -33.76% |
| 2004 | 29.68 Billion USD | -7.72% |
| 2003 | 32.16 Billion USD | 41.71% |
| 2002 | 22.69 Billion USD | 14.21% |
| 2001 | 19.87 Billion USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q2 | 2.02 Million USD | -59.66% |
| 2023 Q1 | 5.01 Million USD | -21.36% |
| 2023 Q3 | 1.58 Million USD | -21.64% |
| 2022 Q4 | 6.38 Million USD | 4.17% |
| 2022 FY | 24.34 Million USD | -19.96% |
| 2022 Q3 | 6.12 Million USD | 9.13% |
| 2022 Q1 | 6.21 Million USD | -5.05% |
| 2022 Q2 | 5.61 Million USD | -9.65% |
| 2021 Q4 | 6.54 Million USD | -28.69% |
| 2021 FY | 30.41 Million USD | 17.15% |
| 2021 Q1 | 7.63 Million USD | 12.98% |
| 2021 Q2 | 7.04 Million USD | -7.73% |
| 2021 Q3 | 9.17 Million USD | 30.21% |
| 2020 Q2 | 745 Million USD | -30.63% |
| 2020 Q1 | 1.07 Billion USD | -38.7% |
| 2020 Q4 | 6.76 Million USD | 12.16% |
| 2020 Q3 | 6.02 Million USD | -99.19% |
| 2020 FY | 25.95 Million USD | 313.95% |
| 2019 Q2 | 1.73 Billion USD | 16.09% |
| 2019 Q4 | 1.75 Billion USD | 9.64% |
| 2019 FY | 6.27 Million USD | -99.92% |
| 2019 Q1 | 1.49 Billion USD | -58.92% |
| 2019 Q3 | 1.59 Billion USD | -7.74% |
| 2018 Q3 | 2.1 Billion USD | 0.0% |
| 2018 Q1 | 1.8 Billion USD | -64.89% |
| 2018 Q4 | 3.63 Billion USD | 72.87% |
| 2018 Q2 | - USD | -100.0% |
| 2018 FY | 7.53 Billion USD | 7.06% |
| 2017 FY | 7.03 Billion USD | 88638.97% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q1 | - USD | -100.0% |
| 2017 Q4 | 5.13 Billion USD | 0.0% |
| 2016 FY | 7.93 Million USD | -20.41% |
| 2016 Q3 | 1.9 Billion USD | -10.09% |
| 2016 Q4 | 4.02 Billion USD | 110.81% |
| 2016 Q2 | 2.12 Billion USD | 0.0% |
| 2016 Q1 | - USD | -100.0% |
| 2015 Q1 | 2.98 Billion USD | 4.01% |
| 2015 Q3 | 2.18 Billion USD | -6.51% |
| 2015 FY | 9.96 Million USD | -99.91% |
| 2015 Q4 | 7.49 Billion USD | 243.24% |
| 2015 Q2 | 2.33 Billion USD | -21.78% |
| 2014 Q4 | 2.87 Billion USD | 2.06% |
| 2014 Q2 | 2.88 Billion USD | 2.24% |
| 2014 Q1 | 2.81 Billion USD | -46.74% |
| 2014 FY | 11.38 Billion USD | 2.15% |
| 2014 Q3 | 2.81 Billion USD | -2.4% |
| 2013 Q3 | 3.3 Billion USD | 30.22% |
| 2013 Q4 | 5.29 Billion USD | 59.9% |
| 2013 FY | 11.14 Billion USD | 4.76% |
| 2013 Q2 | 2.54 Billion USD | 0.0% |
| 2013 Q1 | - USD | -100.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q1 | 2.56 Billion USD | 21740.35% |
| 2012 Q2 | - USD | -100.0% |
| 2012 FY | 10.63 Billion USD | 90595.89% |
| 2012 Q4 | 8.07 Billion USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q1 | - USD | -100.0% |
| 2011 Q4 | 11.72 Million USD | 0.0% |
| 2011 FY | 11.72 Million USD | -23.53% |
| 2010 Q1 | 3.56 Billion USD | -32.04% |
| 2010 Q4 | 6.05 Billion USD | 0.0% |
| 2010 FY | 15.33 Million USD | -56.34% |
| 2010 Q3 | - USD | -100.0% |
| 2010 Q2 | 3.64 Billion USD | 2.3% |
| 2009 Q3 | 3.52 Billion USD | 1.38% |
| 2009 Q4 | 5.24 Billion USD | 48.93% |
| 2009 FY | 35.12 Million USD | -99.77% |
| 2009 Q1 | 253 Million USD | -98.35% |
| 2009 Q2 | 3.47 Billion USD | 1273.91% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q4 | 15.33 Billion USD | 0.0% |
| 2008 FY | 15.33 Billion USD | 7.99% |
| 2008 Q1 | - USD | -100.0% |
| 2007 Q3 | - USD | -100.0% |
| 2007 Q4 | 10.73 Billion USD | 0.0% |
| 2007 FY | 14.2 Billion USD | -59.57% |
| 2007 Q1 | - USD | -100.0% |
| 2007 Q2 | 3.46 Billion USD | 0.0% |
| 2006 Q2 | 24.11 Billion USD | 458.03% |
| 2006 Q4 | 2.58 Billion USD | 0.0% |
| 2006 FY | 35.12 Billion USD | 78.68% |
| 2006 Q1 | 4.32 Billion USD | -14.01% |
| 2005 Q4 | 5.02 Billion USD | 22.41% |
| 2005 Q3 | 4.1 Billion USD | -14.76% |
| 2005 Q2 | 4.81 Billion USD | -15.64% |
| 2005 Q1 | 5.71 Billion USD | -13.92% |
| 2005 FY | 19.65 Billion USD | -33.76% |
| 2004 FY | 29.68 Billion USD | -7.72% |
| 2004 Q2 | 9.15 Billion USD | 22.6% |
| 2004 Q3 | 6.42 Billion USD | -29.85% |
| 2004 Q1 | 7.46 Billion USD | -69.43% |
| 2004 Q4 | 6.63 Billion USD | 3.27% |
| 2003 Q3 | 6.76 Billion USD | -12.53% |
| 2003 Q2 | 7.73 Billion USD | 0.0% |
| 2003 FY | 32.16 Billion USD | 41.71% |
| 2003 Q4 | 24.42 Billion USD | 261.11% |
| 2003 Q1 | - USD | -100.0% |
| 2002 Q2 | 6.11 Billion USD | 0.86% |
| 2002 FY | 22.69 Billion USD | 14.21% |
| 2002 Q4 | 5.63 Billion USD | 15.49% |
| 2002 Q3 | 4.88 Billion USD | -20.15% |
| 2002 Q1 | 6.06 Billion USD | 0.0% |
| 2001 FY | 19.87 Billion USD | 0.0% |
| 2001 Q2 | - USD | 0.0% |
| 2001 Q3 | 4.88 Billion USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| The Amacore Group, Inc. | 64.06 Million USD | 92.192% |
| Arem Pacific Corporation | 367.08 Thousand USD | -1262.842% |
| Assisted 4 Living, Inc. | 833.9 Thousand USD | -499.915% |
| BioCorRx Inc. | 3.84 Million USD | -30.246% |
| Bionik Laboratories Corp. | 5.81 Million USD | 13.967% |
| Banyan Corp. | 6.59 Million USD | 24.173% |
| Dental Patient Care America, Inc. | 3.27 Million USD | -52.715% |
| Quantum Medical Transport, Inc. | 874.76 USD | -571796.292% |
| Empower Clinics Inc. | 6.92 Million USD | 27.731% |
| First Choice Healthcare Solutions, Inc. | 2.44 Million USD | -104.995% |
| Selectis Health, Inc. | 14.36 Million USD | 65.18% |
| Ethema Health Corporation | 5.27 Million USD | 5.11% |
| HealthLynked Corp. | 9.73 Million USD | 48.593% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | 9.43 Million USD | 46.999% |
| JRSIS Health Care Corporation | 671.64 Thousand USD | -644.841% |
| Comjoyful International Company | - USD | -Infinity% |
| Medical Facilities Corporation | 75.35 Million USD | 93.361% |
| MedSmart Group Inc. | 65.47 Thousand USD | -7541.124% |
| North America Frac Sand, Inc. | 775.75 Thousand USD | -544.884% |
| Nova Leap Health Corp. | 9.3 Million USD | 46.255% |
| Nexteligent Holdings, Inc. | 553.38 Thousand USD | -804.015% |
| PAO Group, Inc. | 45.42 Thousand USD | -10914.355% |
| Primemd Inc. | 6.25 Million USD | 20.057% |
| Raffles Medical Group Ltd | 151.69 Million USD | 96.702% |
| Ryman Healthcare Limited | 9.61 Million USD | 47.959% |
| Stem Cell Authority, Ltd. | 4233.00 USD | -118083.794% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | 1.38 Million USD | -262.313% |
| Mycotopia Therapies, Inc. | 616.72 Thousand USD | -711.176% |
| U.S. NeuroSurgical Holdings, Inc. | 765 Thousand USD | -553.95% |
| Veltex Corporation | 1.77 Million USD | -181.509% |
| World Financial Holding Group | 28.42 Thousand USD | -17499.099% |
| Xcelerate Inc. | 2.9 Million USD | -72.105% |